Overview

A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura

Status:
Unknown status

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

This is an open label 6 month pilot study for male and female participants over the age of 52 that desire treatment and prevention of senile purpura of the forearms. This study will be evaluating the effects of Adapalene 0.3% for the use in the treatment and prevention of senile purpura.

Phase:

Phase 2

Details

Lead Sponsor:

Multispecialty Aesthetic Clinical Research Organization

Collaborator:

Galderma Laboratories, L.P.

Treatments:

Adapalene